NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application

NanoViricides has signed a consulting agreement with Biologics Consulting Group (BCG) in order to prepare and submit the Investigational New Drug (IND) applications to the Food and Drug Administration (FDA) for approval of its nanoviricides drug candidates to treat different viral diseases.

The success of FluCide drug candidates in pre-medical animal studies has already been reported by NanoViricides. The company is involved in the preparation of FluCide investigational anti-influenza drug. The company will receive guidance from BCG regarding filling of the pre-IND application to successfully complete FDA approval and evaluation process. BCG will assist NanoViricides in scheduling and applying extra pre-clinical development activities that are required for the IND application.

Additionally, the company expects that while submitting the first IND application to the FDA, it should have produced some amount of drug candidates associated to the product under current Good Manufacturing Practices (cGMP) conditions. The company has declared that it will be leasing facilities so as to be able tomeet the cGMP requirements in a specified period.

BCG, an international consulting organization provides guidance about both national and international regulations and helps in commercial developmental processes for producing drug, device, and biological products. BCG has knowledge in product production and testing, facility inspections, regulatory affairs, pharmacology, toxicology, medical trial design and assessment, statistics, and program management.

Source: www.nanoviricides.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application. AZoNano. Retrieved on March 02, 2024 from https://www.azonano.com/news.aspx?newsID=22898.

  • MLA

    Chai, Cameron. "NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application". AZoNano. 02 March 2024. <https://www.azonano.com/news.aspx?newsID=22898>.

  • Chicago

    Chai, Cameron. "NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application". AZoNano. https://www.azonano.com/news.aspx?newsID=22898. (accessed March 02, 2024).

  • Harvard

    Chai, Cameron. 2019. NanoViricides Enters Consulting Agreement with BCG for Submitting IND Application. AZoNano, viewed 02 March 2024, https://www.azonano.com/news.aspx?newsID=22898.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.